Log In
BCIQ
Print this Print this
 

SER101 (RO1160367)

  Manage Alerts
Collapse Summary General Information
Company Roche
DescriptionSelective serotonin (5-HT4) receptor antagonist
Molecular Target Serotonin (5-HT4) receptor
Mechanism of ActionSerotonin (5-HT4) receptor antagonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationHeart failure
Indication DetailsTreat heart failure
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

12/13/2010

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today